Health • Retail • FMCG
We may be mislabelling the Ozempic story.
GLP-1 medicines are a healthcare story. But they are also a demand story for retail and FMCG.
Felix Ghauri ·
FMCG
2 insights on this topic
Healthcare • Economics • Business
The Ozempic Demand Story: GLP-1 and the 5.3% drop in food spending.
GLP-1 medicines are a healthcare story, but they are also a fundamental demand story reshaping low-margin FMCG.
Felix Ghauri ·